↓ Skip to main content

Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial

Overview of attention for article published in The Lancet, August 2005
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Citations

dimensions_citation
896 Dimensions

Readers on

mendeley
650 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial
Published in
The Lancet, August 2005
DOI 10.1016/s0140-6736(05)67176-0
Pubmed ID
Authors

Arjen Dondorp, François Nosten, Kasia Stepniewska, Nick Day, Nick White

Abstract

In the treatment of severe malaria, intravenous artesunate is more rapidly acting than intravenous quinine in terms of parasite clearance, is safer, and is simpler to administer, but whether it can reduce mortality is uncertain.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 650 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 4 <1%
Brazil 3 <1%
Portugal 2 <1%
Belgium 2 <1%
Thailand 2 <1%
Kenya 2 <1%
India 2 <1%
Germany 1 <1%
Malaysia 1 <1%
Other 4 <1%
Unknown 627 96%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 112 17%
Student > Master 106 16%
Researcher 89 14%
Student > Ph. D. Student 74 11%
Other 56 9%
Other 122 19%
Unknown 91 14%
Readers by discipline Count As %
Medicine and Dentistry 251 39%
Agricultural and Biological Sciences 70 11%
Biochemistry, Genetics and Molecular Biology 55 8%
Pharmacology, Toxicology and Pharmaceutical Science 40 6%
Chemistry 29 4%
Other 95 15%
Unknown 110 17%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 37. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 March 2024.
All research outputs
#1,100,617
of 25,374,647 outputs
Outputs from The Lancet
#8,312
of 42,669 outputs
Outputs of similar age
#1,406
of 68,158 outputs
Outputs of similar age from The Lancet
#16
of 180 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 42,669 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 67.9. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 68,158 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 180 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.